期刊文献+

肝外胆管癌中染色体9p21区段抑癌基因簇表达异常的研究 被引量:7

The Study of Relationship between Inactivation of Tumor Suppressor Gene Cluster Located in Chromosome 9p21 and Progression of Extra-hepatic Bile Duct Cancer
在线阅读 下载PDF
导出
摘要 目的 研究位于 9号染色体短臂 2 1段的抑癌基因簇所包含的 3个抑癌基因 p14 /ARF、p15 /INK4B和p16 /INK4A在肝外胆管癌组织中的异常表达 ,探讨这 3个抑癌基因的表达异常在肝外胆管癌的发生发展过程中的作用。方法 应用免疫组织化学方法研究肝外胆管癌肿瘤组织、癌旁组织以及胆管炎组织的石蜡切片中p14、p15和 p16蛋白的表达。 结果 肝外胆管癌组织、癌旁组织以及胆管炎组织中 p14 /ARF、p16 /INK4A两个基因表达缺失率两两比较均有显著性差异 (P <0 .0 5 ) ,而 p15 /INK4B基因在各组中的表达无显著性差异 (P >0 .0 5 )。 3个基因的表达异常与肿瘤的组织学类型无关 ,在伴有淋巴结转移 /局部浸润的病例中缺失率明显增高 (P <0 .0 5 )。结论 p14 /ARF、p16 /INK4A基因表达异常早期参与了肝外胆管癌发生。 Objective To study the abnormal expression of three tumor suppressor p14/ARF, p15/INK4B and p16/INK4A located in chromosome 9p21 in the tissue of extra-hepatic bile duct cancer, and to discuss the possible role of these three genes in the initiation and progression of bile duct cancer.Methods The expression of p14, p15 and p16 proteins in the tissues of tumor, tumor side and cholangitis were studied using the method of immunohistochemistry.Results The rates of p14/ARF and p16/INK4A gene expression loss in the tumor tissue were higher than that in tumor side tissue and cholangitis tissue, and there was no significant difference between different pathology types.Conclusion The abnormal expression of p14/ARF and p16/INK4A gene may play a role in the initiation and progression of extra-hepatic bile duct cancer.
出处 《肿瘤防治研究》 CAS CSCD 2004年第9期523-525,F002,共4页 Cancer Research on Prevention and Treatment
关键词 肝外胆管癌 染色体 抑癌基因 免疫组织化学 Bile duct cancer Chromosome Tumor suppressor Immunohistochemistry
  • 相关文献

参考文献9

  • 1[1]Kawasaki H, Altieri DC, Lu CD, et al. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer[J]. Cancer Res, 1998,58(22) :5071-5074.
  • 2[2]Sasaki S, Kitagawa Y, Sekido Y, et al. Molecular processes of chromosome 9p21 deletions in human cancers[J]. Oncogene, 2003,22(24):3792-3798.
  • 3[3]Calero Moreno TM, Gustafsson G, Garwicz S, et al. Deletion of the Ink4-locus (the p16ink4a, P14arf and p15ink4b genes) predicts relapse in children with ALL treated according to the Nordic protocols NOPHO-86 and NOPHO-92[J]. Leukemia, 2002,16(10):2037-2045.
  • 4[4]Kaye FJ. RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer[J]. Oncogene, 2002,21(45):6908-6914.
  • 5[5]Peng CY, Chen TC, Hung SP, et al. Genetic al terations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma[J]. Anticancer Res, 2002,22(2B) :1265-1271.
  • 6[6]Bazan V, Zanna I, Migliavacca M, et al. Prognostic significance of p16IN K4a alterations and 9p21 loss of heterozygosity in locally advanced laryngeal squamous cell carcinoma[J]. J Cell Physiol, 2002,192(3):286-293.
  • 7[7]Yoshida S, Todoroki T, Ichikawa Y, et al. Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers[J]. Cancer Res, 1995,55(13):2756 -2760.
  • 8[8]Tannapfel A, Sommerer F, Benicke M, et al. Genetic and epigenetic alterat ions of the INK4a-ARF pathway in cholangiocarcinoma[J]. J Pathol, 2002,197(5) :624-631.
  • 9[9]Caca K, Feisthammel J, Klee K, et al. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines[J]. Int J Cancer, 2002,97(4):481-488.

同被引文献52

引证文献7

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部